,i #aaeth ,,congress #b;d ,session ,h4 ,r4 #fafe ,,in ,,the ,,house ,,of ,,representatives ,june #bj1 #bjah,mr4 ,o',halleran 7for himself1 ,mr4 ,knight1 and ,mr4 ,moulton7 introduced the following bill2 which was referred to the ,committee on ,armed ,services ,a ,,bill ,to improve the treatment of opioids under the pharmacy benefits program of the ,department of ,defense4 #a4 ,short title ,this ,act may be cited as the ,combating ,opioid ,misuse ,before ,addiction for our ,troops ,act or the ,,combat ,act4 #b4 ,treatment of opioids under the pharmacy benefits program of the ,department of ,defense 7a7 ,supply ,except as provided by subsection 7b71 and except as otherwise provided by the prescribing medical professional1 in carrying out the pharmacy benefits program under section #ajgd;g of title #aj1 ,united ,states ,code1 the ,secretary of ,defense shall ensure that-- 7#a7 the first prescription for an opioid provided during a course of treatment is limited to a seven-day supply of the opioid2 and 7#b7 any further supply is subject to a renewal of the prescription4 7b7 ,exception ,the limitation in subsection 7a7 shall not apply with respect to an individual who-- 7#a7 suffers from chronic pain and participates in a pain management program2 7#b7 is being treated for cancer2 7#c7 is being treated for a traumatic injury2 7#d7 is being treated for opioid or substance abuse disorder2 7#e7 receives hospice care2 or 7#f7 receives palliative care4